PRODUCT NAME:

Valproic Acid Determination Kit (VPA Determination Kit) Abbreviation: VPA 

INTENDED USE:

Valproic Acid Determination Kit is an in vitro diagnostic test for the quantitative detection of VPA in human serum and plasma specimens. Valproic acid is a widely recognized broad-spectrum antiepileptic drug, which is mainly used to treat various types of epileptic seizures, including generalized tonic-clonic seizures, myoclonic seizures, and petit mal. In addition, valproic acid can also be used for a variety of psychiatric and neurological diseases, such as bipolar neuronal disorder, schizophrenia, depression, neuralgia, migraine, Alzheimer's disease and other neurological disorders. It is a broad-spectrum drug and first-line drug for the clinical treatment of epilepsy. It is frequently used clinically. However, due to the large differences in the pharmacokinetics and pharmacodynamics of different individuals, the dosage of valproic acid is difficult to control. In order to control epileptic seizures, maximize the curative effect and reduce adverse reactions, therapeutic drug monitoring is required during the clinical application of valproic acid in the treatment of epilepsy.